Local Institution

Chennai 680004

0 studies enrolling now · 12 studies all time

What they study most

Atrial Fibrillation, Atrial Flutter, Bipolar Disorder, Chronic Kidney Failure, Depression, Diabetes, Diabetes Mellitus, Type 2, Hepato Cellular Carcinoma (HCC), Kidney Transplantation, Liver Cancer, Type 2 Diabetes Mellitus, Venous Thrombosis

Studies at this site

• Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment — Completed
• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
• Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment — Completed
• First Line Hepato Cellular Carcinoma (HCC) — Completed
• Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT) — Completed
• Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression — Completed
• Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression — Stopped early
• A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise — Completed
• A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone — Completed
• Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism — Completed
• A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode — Withdrawn before enrolling
• Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes — Completed